• Home
  • Team Accent
  • Our Scientific Focus
  • Our Approach
  • News & Events
  • Publications
  • Careers
  • Contact Us
Accent Therapeutics

Our Scientific Focus

Introduction to epitranscriptomics

Accent President Robert Copeland explains epitranscriptomics and the Accent mission to translate this extraordinary new area of biology into life-changing cancer therapies

Publications

Buker, S.M., Gurard-Levin, Z.A., Wheeler, B.D. ... Boriack-Sjodin, P.A. A Mass Spectrometric Assay of METTL3/METTL14 Methyltransferase Activity. SLAS Discovery, doi: 10.1177/2472555219878408 (2019).

Han, D., Lui, J., Chen, C., Dong, L., Liu, Y. ... He, C. Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature 566, 270-274, doi: 10.1038/s41586-019-0916-x (2019).

Buker, S.M., Boriack-Sjodin, P.A., & Copeland, R.A. Enzyme-Inhibitor Interactions and a Simple, Rapid Method for Determining Inhibition Modality. SLAS Discovery, doi: 10.1177/2472555219829898 (2019).

» View all publications

Introduction to epitranscriptomics
RNA-modifying proteins
RMPs and cancer

Careers

Our mission is to translate extraordinary science to life-changing therapies for patients in need. We are looking for driven, creative individuals to accentuate our team: learn more about our values and the benefits of a career at Accent Therapeutics!

» Join Accent

  • Privacy Policy
  • Contact
©2023 ACCENT THERAPEUTICS
Accent Therapeutics